Context Therapeutics EPS Diluted from Extraordinaries (Quarterly) Trends

Context Therapeutics, Inc. (CNTX)

2.24 -0.08 (-3.45%) USD | NASDAQ | Feb 20, 16:00

2.23 -0.01 (-0.45%) After-Hours: 20:00

View EPS Diluted from Extraordinaries (Quarterly) for CNTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Imunon, Inc.	--